Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Entresto in ckd?

See the DrugPatentWatch profile for Entresto

Is Entresto (sacubitril/valsartan) used for CKD?

Entresto is prescribed for heart failure, and CKD often occurs alongside heart failure. Treatment decisions in people with chronic kidney disease typically focus on kidney function and potassium levels, because sacubitril/valsartan can affect both.

What kidney risks come up in CKD patients taking Entresto?

In CKD, the main practical concerns with Entresto are:
- Higher potassium levels (hyperkalemia)
- Changes in kidney function (a rise in creatinine can occur, especially after starting or increasing doses)
- Lower blood pressure (which can reduce kidney perfusion in some patients)

Clinicians generally monitor serum creatinine/eGFR and potassium soon after starting and after dose changes.

Does CKD change the way doctors start or titrate Entresto?

Yes. In CKD, doctors commonly use a more cautious approach:
- starting at a lower dose or using standard starting doses with closer lab monitoring (eGFR-dependent decisions are typical in practice)
- avoiding dose increases until potassium and kidney function are stable

What about dialysis or very advanced CKD?

For people with end-stage kidney disease or those on dialysis, evidence and prescribing practices are more limited than for earlier CKD stages, so dosing and risk monitoring become especially individualized.

What drug interactions matter most in CKD?

In CKD, risk of hyperkalemia and kidney strain is higher when Entresto is combined with other medications that raise potassium or affect kidney function, such as:
- potassium-sparing diuretics (for example, spironolactone or eplerenone)
- ACE inhibitors or other RAAS blockers (depending on how therapy is sequenced)
- NSAIDs (commonly linked to kidney stress, especially when kidney reserve is limited)

Clinicians typically reassess the medication list and monitoring plan when Entresto is started.

What do patients with CKD ask most often?

Common questions include:
- How soon will labs be checked after starting Entresto?
- What potassium level would mean the dose needs to be reduced or stopped?
- Can I take NSAIDs for pain while on Entresto if I have CKD?

Those answers depend on CKD stage, baseline kidney function, and existing heart failure regimen.

Sources

No reliable, specific CKD-Entresto statements were provided in the prompt for citation. If you share the CKD stage (e.g., eGFR range) or whether the context is heart failure with reduced EF, heart failure with preserved EF, or another indication, I can tailor the answer.



Other Questions About Entresto :

Entresto and renal failure? Entresto and hypotension? Can entresto cause kidney problems? Entresto and ckd? Does entresto damage kidneys? Is there a generic version of entresto available? Entresto side effects patient reviews?